C. Michelet

4.6k total citations
94 papers, 2.5k citations indexed

About

C. Michelet is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, C. Michelet has authored 94 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 38 papers in Epidemiology and 22 papers in Virology. Recurrent topics in C. Michelet's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (12 papers). C. Michelet is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (12 papers). C. Michelet collaborates with scholars based in France, United States and Switzerland. C. Michelet's co-authors include Pierre Tattevin, C. Arvieux, F Cartier, Danièle Bentué‐Ferrer, Yves Le Tulzo, Olivier Tribut, François Raffi, Matthieu Revest, S. Minjolle and Christophe Camus and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Langmuir.

In The Last Decade

C. Michelet

92 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
C. Michelet 1.1k 1.1k 494 277 238 94 2.5k
Víctor Asensi 711 0.7× 963 0.9× 331 0.7× 210 0.8× 288 1.2× 128 2.3k
Sharon Safrin 1.6k 1.5× 2.6k 2.5× 824 1.7× 260 0.9× 225 0.9× 65 4.8k
Vicenç Falcó 1.2k 1.1× 1.6k 1.5× 709 1.4× 303 1.1× 436 1.8× 150 3.0k
Bruno Cacopardo 779 0.7× 1.2k 1.2× 253 0.5× 428 1.5× 225 0.9× 171 3.1k
Karina Butler 1.4k 1.3× 975 0.9× 657 1.3× 268 1.0× 102 0.4× 108 2.6k
Vicente Pintado 1.3k 1.2× 1.5k 1.4× 364 0.7× 489 1.8× 274 1.2× 76 3.2k
Beverly E. Sha 828 0.8× 1.1k 1.0× 722 1.5× 140 0.5× 195 0.8× 84 2.4k
A Vierucci 442 0.4× 1000 0.9× 317 0.6× 334 1.2× 314 1.3× 160 3.4k
Sandor Feldman 1.2k 1.1× 3.2k 3.0× 326 0.7× 334 1.2× 187 0.8× 91 4.3k
Francesco Chiodo 1.5k 1.4× 1.0k 1.0× 759 1.5× 264 1.0× 399 1.7× 215 3.1k

Countries citing papers authored by C. Michelet

Since Specialization
Citations

This map shows the geographic impact of C. Michelet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Michelet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Michelet more than expected).

Fields of papers citing papers by C. Michelet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Michelet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Michelet. The network helps show where C. Michelet may publish in the future.

Co-authorship network of co-authors of C. Michelet

This figure shows the co-authorship network connecting the top 25 collaborators of C. Michelet. A scholar is included among the top collaborators of C. Michelet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Michelet. C. Michelet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Revest, Matthieu, Cédric Jacqueline, J. Caillon, et al.. (2016). Newin vitroandin vivomodels to evaluate antibiotic efficacy inStaphylococcus aureusprosthetic vascular graft infection. Journal of Antimicrobial Chemotherapy. 71(5). 1291–1299. 19 indexed citations
2.
Revest, Matthieu, et al.. (2014). Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases. Médecine et Maladies Infectieuses. 44(6). 251–260. 14 indexed citations
3.
Corre, Pascal Le, et al.. (2014). Causes and consequences of anti-infective drug stock-outs. Médecine et Maladies Infectieuses. 44(10). 470–477. 6 indexed citations
4.
Revest, Matthieu, Caroline Piau, Céline Chabanne, et al.. (2014). Heart transplantation as salvage treatment of intractable infective endocarditis. Clinical Microbiology and Infection. 21(4). 371.e1–371.e4. 11 indexed citations
5.
Lamiraud, Karine, Jean‐Paul Moatti, F. Raffi, et al.. (2012). Adherence to and Effectiveness of Highly Active Antiretroviral Treatment for HIV Infection. Medical Care. 50(5). 410–418. 7 indexed citations
6.
Chapplain, Jean-Marc, Pierre Tattevin, Dominique Guyader, et al.. (2011). Mitochondrial Abnormalities in Patients with HIV-HCV Co-infection as Compared to Patients with HCV Mono-infection. HIV Clinical Trials. 12(1). 54–60. 6 indexed citations
7.
8.
Fily, F., Claire Haegelen, Pierre Tattevin, et al.. (2011). Deep Brain Stimulation Hardware-Related Infections: A Report of 12 Cases and Review of the Literature. Clinical Infectious Diseases. 52(8). 1020–1023. 37 indexed citations
9.
Gilson, Mélanie, Laure Gossec, Xavier Mariette, et al.. (2010). Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study. Arthritis Research & Therapy. 12(4). R145–R145. 46 indexed citations
10.
Calès, Paul, Philippe Halfon, Dominique Batisse, et al.. (2010). Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. Journal of Hepatology. 53(2). 238–244. 35 indexed citations
11.
Maillard, Anne, Jean-Marc Chapplain, Olivier Tribut, et al.. (2007). The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir–ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients. Journal of Clinical Virology. 38(2). 131–138. 13 indexed citations
12.
Rosenthal, Éric, Gilles Pialoux, N. Bernard, et al.. (2006). Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)*. Journal of Viral Hepatitis. 14(3). 183–188. 106 indexed citations
13.
Tattevin, Pierre, Faouzi Souala, Matthieu Revest, Delphine Taussig, & C. Michelet. (2006). Confusion, memory disorders, and ophthalmoparesis in a patient with AIDS. The Lancet. 367(9507). 368–368. 4 indexed citations
14.
Tattevin, Pierre, Olivier Tribut, C. Arvieux, et al.. (2005). Use of high-performance liquid chromatography (HPLC) to monitor β-lactam plasma concentrations during the treatment of endocarditis. Clinical Microbiology and Infection. 11(1). 76–79. 18 indexed citations
15.
Jouneau, S., et al.. (2004). Vertebral osteomyelitis presenting as exudative pleural effusion. European Journal of Internal Medicine. 15(5). 323–325. 2 indexed citations
16.
Tattevin, Pierre, et al.. (2003). Manifestations métastatiques cutanées de la maladie de Crohn. La Revue de Médecine Interne. 24(3). 198–201. 5 indexed citations
17.
Moing, Vincent Le, Rodolphe Thiébaut, Geneviève Chêne, et al.. (2002). Predictors of Long‐Term Increase in CD4+Cell Counts in Human Immunodeficiency Virus–Infected Patients Receiving a Protease Inhibitor–Containing Antiretroviral Regimen. The Journal of Infectious Diseases. 185(4). 471–480. 90 indexed citations
18.
Michelet, C., Éric Bellissant, Annick Ruffault, et al.. (1999). Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine. Clinical Pharmacology & Therapeutics. 65(6). 661–671. 6 indexed citations
19.
20.
Camus, Christophe, C. Leport, F. Raffi, et al.. (1993). Sustained Bacteremia in 26 Patients with a Permanent Endocardial Pacemaker: Assessment of Wire Removal. Clinical Infectious Diseases. 17(1). 46–55. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctor Asensi Breakdown of academic impact, for papers by Sharon Safrin Breakdown of academic impact, for papers by Vicenç Falcó Breakdown of academic impact, for papers by Bruno Cacopardo Breakdown of academic impact, for papers by Karina Butler Breakdown of academic impact, for papers by Vicente Pintado Breakdown of academic impact, for papers by Beverly E. Sha Breakdown of academic impact, for papers by A Vierucci Breakdown of academic impact, for papers by Sandor Feldman Breakdown of academic impact, for papers by Francesco Chiodo
Rankless by CCL
2026